Society of Nuclear Medicine and Molecular Imaging (SNMMI)

Download the SNMMI Annual Meeting Preview Magazine!

This Month in The Journal of Nuclear Medicine

Get a preview of what's happening at the SNMMI 2023 Annual Meeting. This issue features details on the new “Eye on U” and “Best of” sessions, the new Knowledge Bowl format and details on categorical sessions, schedule and more! Download your copy, then finalize your registration for this year's meeting!

Effective May 2, your username for the SNMMI website is now your primary email address. No action is needed from you regarding this change. However, if you would like to change your primary email address, please log in to MySNMMI to review and update your primary email address or contact login@snmmi.org.

In May JNM: Defining theranostics…Focus on general NM…Discussion: Future of prostate cancer treatment…Somatostatin-based theranostics…a-Radioligand therapy…Featured: FAPI PET for oncologic imaging…Lu-177 FAP6-IP-DOTA therapy…and more.

SNMMI’s Consumer Media Initiative continues to work to raise awareness of nuclear medicine. To date, the program has resulted in media engagements on NBC, CBS, FOX and more—reaching well over a billion viewers. Check out recent interviews on our YouTube channel!

SNMMI is excited to announce the release of the new MIRD Primer 2022: A Complete Guide to Radiopharmaceutical Dosimetry—a comprehensive, state-of-the-art guide to radiopharmaceutical dosimetry that reflects the dramatic evolution of the field of nuclear medicine, including molecular imaging and, increasingly, radiopharmaceutical therapy. Purchase your copy.

SNMMI NEWS

May 26, 2023 — SNMMI Opposes Proposed LCD to Restrict Care for Patients
SNMMI submitted comments to CMS urging the withdrawal of the proposed Local Coverage Determination, Positron Emission Tomography (PET) Scan for Inflammation and Infection (DL39521) (Government Relations News)
May 17, 2023 — Make Connections—Unlock the Power of Networking
Are you looking to take your career to the next level? Do you want to make valuable connections that can help you achieve your professional goals? (SNMMI News)
May 15, 2023 — Celebrate Clinical Trials Day with the SNMMI Clinical Trials Network!
The SNMMI Clinical Trials Network (CTN) is celebrating Clinical Trials Day on Saturday, May 20! (SNMMI News)
May 12, 2023 — Amino Acid PET Successfully Differentiates Recurrent Brain Metastases, Reducing Invasive Procedures and Overtreatment
A new meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes, potentially reducing overtreatment, according to research published in May JNM. (Press Releases)
May 1, 2023 — New Research: FAPI PET Imaging Superior for Diagnosing Multiple Types of Cancer, with Potential for Targeted Treatment
Two articles in the May issue of JNM illustrate the promise of the novel FAPI radiotracer. Results from the largest study of patients undergoing 68Ga-FAPI PET demonstrate the superiority of 68Ga-FAPI over standard 18F-FDG PET in evaluating multiple types of cancer. In a separate study, a newly designed FAPI-targeted treatment was found to suppress tumor growth in several common cancers in a preclinical setting. These advances have strong potential to provide more precise staging and management for cancer patients. (Press Releases)
April 21, 2023 — Novartis Announces FDA Approval for New Jersey Facility to Produce Pluvicto for Commercial Use
Today Novartis announced that it has received FDA approval to supply Pluvicto from its plant in Millburn, New Jersey. The company is planning to ramp up production in the coming weeks. (SNMMI News)
April 20, 2023 — SNMMI Celebrates National Volunteer Week
A special thank you to all our members who volunteer their time, talent, and expertise to meet the critical needs of the nuclear medicine and molecular imaging community. (SNMMI News)
April 19, 2023 — Newly Developed PSG Score Improves Patient Selection for PSMA Radiopharmaceutical Therapy
International, multicenter testing demonstrated the effectiveness of a newly established PSMA PET scoring system that can successfully predict whether metastatic castration-resistant prostate cancer patients will respond to treatment with Lu-177 PSMA therapy. The research was published online in JNM. (Press Releases)

CONTINUING EDUCATION

New! ASNC/SNMMI 80 Hour Authorized User Training Course

The new online ASNC/SNMMI 80 Hour Authorized User Training Course is designed to provide nuclear medicine physicians with the knowledge needed to establish a culture of safety and quality in their practice. Learn More »

New! SNMMI Qualified Systems Personnel Training Program (QSPTP)

The SNMMI Qualified Systems Personnel Training Program (QSPTP) has been developed to define the competencies of a Qualified Person in the release of manufactured radiopharmaceuticals, providing experts in the field of radiopharmaceutical science guidance in program development. Learn More »

SNMMI Webinars

Access upcoming and recorded webinars from the new SNMMI Webinars website. Learn More »

Nuclear Medicine Online Review Course

Covering the most essential topics in nuclear medicine—you'll build the level of expertise you need to ace your exam! AMA PRA Category 1 credits available. Learn More »

Radiation Safety+ Review and Essentials

The Radiation Safety+ Review and Essentials program provides a comprehensive overview of all aspects of radiation safety for nuclear medicine technologists preparing to take the NMTCB’s Radiation Safety Certification Examination. Learn More »

CT+ Review and Essentials

CT+ Review and Essentials provides you with the comprehensive didactic education you need to succeed, whether you're looking to build your general CT knowledge, or preparing to sit for the ARRT (CT) and/or NMTCB (CT) exam(s). Learn More »

Member Benefit! Complimentary Journal SAMs/Journal CE

Free Journal SAM/CE access is available exclusively for SNMMI Members. Take advantage of this great benefit and meet your certification requirements. Learn more »

PUBLICATIONS

Journal of Nuclear Medicine

VIEW CURRENT ISSUE
Journal of Nuclear Medicine Technology

VIEW CURRENT ISSUE
Molecular Imaging
Journal

VIEW CURRENT ISSUE

FEDERAL LEGISLATIVE EFFORTS

The FIND Act – Learn more »

MOLECULAR IMAGING NEWS

May 31, 2023

EDUCATION AND RESEARCH FOUNDATION

ERF secures, invests and distributes funding to support rigorously vetted physicians, scientists and technologists in the pursuit of advanced academic studies or breakthrough discoveries in the field. Learn More »